RYA
GNLX icon

Richard Young Associates’s Genelux GNLX Stock Holding History

Richard Young Associates’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Hold
40,959
– – 0.08% 29
2026
Q1 		$99.1K Hold
40,959
– – 0.08% 25
2025
Q4 		$179K Buy
+40,959
New +$221K 0.14% 25

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

Richard Young Associates's GNLX Position: Q2 2026 in Review

Richard Young Associates held its Genelux (GNLX) position steady in Q2 2026 at 40,959 shares worth $123K. The position accounts for 0.08% of the portfolio, ranked #29.

Richard Young Associates first reported a position in GNLX in Q4 2025 and has held it in 3 quarters since. The position peaked at $179K in Q4 2025. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Richard Young Associates held 40,959 shares of Genelux worth $123K as of Q2 2026.
  • Richard Young Associates left its Genelux share count unchanged in Q2 2026.
  • Genelux made up 0.08% of Richard Young Associates's portfolio in Q2 2026, its #29 holding.
  • Richard Young Associates first reported a position in Genelux in Q4 2025 and has held it in 3 quarters since.
  • Richard Young Associates's Genelux position peaked at $179K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Richard Young Associates's 13F filing for Q2 2026, filed 27 Jul 2026.